Literature DB >> 9773731

The 1997 American Diabetes Association criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance: poor agreement in the Hoorn Study.

F de Vegt1, J M Dekker, C D Stehouwer, G Nijpels, L M Bouter, R J Heine.   

Abstract

OBJECTIVE: Recently, the American Diabetes Association (ADA) introduced new diagnostic criteria. These new criteria are based on fasting plasma glucose levels, avoiding the burdensome oral glucose tolerance test (OGTT). We compared the 1997 ADA criteria with the 1985 World Health Organization (WHO) criteria with respect to the prevalence of diabetes and the cardiovascular risk profile in the population of the Hoorn Study RESEARCH DESIGN AND METHODS: The Hoorn Study is a population-based survey of 2,484 men and women, aged 50-75 years. An OGTT was performed and cardiovascular risk factors were determined in 2,378 subjects without known diabetes. Subjects were categorized according to both sets of diagnostic criteria.
RESULTS: Although the prevalence of diabetes was similar for both sets of criteria, 47 of 120 (39.2%) subjects who were diagnosed with diabetes according to the 1997 ADA criteria were not classified as having diabetes when using the 1985 WHO criteria. Similarly, of 285 subjects diagnosed with impaired fasting glucose by the 1997 ADA criteria, 195 (68.4%) were classified as having normal glucose tolerance by the 1985 WHO criteria. The overall agreement was poor (kappa 0.33; 95% CI 0.28-0.38). Subjects who were diagnosed as having diabetes by either set of criteria had an adverse cardiovascular risk profile, which was between the cardiovascular risk profiles of concordant normal and concordant diabetic subjects.
CONCLUSIONS: In this study both sets of criteria diagnosed a similar number of diabetic subjects, but many of the subjects shifted between glucose intolerance categories. With either set of criteria, a considerable number of subjects at risk of developing diabetes and subjects carrying an increased risk of cardiovascular disease, as reflected by an adverse cardiovascular risk profile, will be missed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9773731     DOI: 10.2337/diacare.21.10.1686

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  30 in total

1.  [Acarbose for prevention of diabetes mellitus. STOP-NIDDM]].

Authors:  E Windler
Journal:  Internist (Berl)       Date:  2003-04       Impact factor: 0.743

2.  Characterisation of subjects with early abnormalities of glucose tolerance in the Stockholm Diabetes Prevention Programme: the impact of sex and type 2 diabetes heredity.

Authors:  J Kuhl; A Hilding; C G Ostenson; V Grill; S Efendic; P Båvenholm
Journal:  Diabetologia       Date:  2004-12-24       Impact factor: 10.122

3.  Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark.

Authors:  S S Rasmussen; C Glümer; A Sandbaek; T Lauritzen; K Borch-Johnsen
Journal:  Diabetologia       Date:  2006-12-02       Impact factor: 10.122

Review 4.  Epidemiology of the insulin resistance syndrome.

Authors:  James B Meigs
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

Review 5.  Should the insulin resistance syndrome be treated in the elderly?

Authors:  Richard W Grant; James B Meigs
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

Review 6.  Pathophysiology of prediabetes.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  Curr Diab Rep       Date:  2009-06       Impact factor: 4.810

7.  Patterns of changes in fasting plasma glucose, hemoglobin A1c and the area under the curve during oral glucose tolerance tests in prediabetic subjects: results from a 16-year prospective cohort study among first-degree relatives of type 2 diabetic patients.

Authors:  Shahla Safari; Masoud Amini; Ashraf Aminorroaya; Awat Feizi
Journal:  Acta Diabetol       Date:  2020-10-21       Impact factor: 4.280

8.  The relationship between fasting hyperglycemia and insulin secretion in subjects with normal or impaired glucose tolerance.

Authors:  Muhammad A Abdul-Ghani; Masafumi Matsuda; Rucha Jani; Christopher P Jenkinson; Dawn K Coletta; Kohei Kaku; Ralph A DeFronzo
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-05-20       Impact factor: 4.310

9.  Glucose tolerance in a rural population of Bangladesh.

Authors:  M A Rahim; A K Azad Khan; S M K Ali; Q Nahar; A Shaheen; A Hussain
Journal:  Int J Diabetes Dev Ctries       Date:  2008-04

Review 10.  Plasma glucose concentration and prediction of future risk of type 2 diabetes.

Authors:  Muhammad A Abdul-Ghani; Ralph A DeFronzo
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.